Veronica Steri, PhD

InstitutionUniversity of California San Francisco
DepartmentHDF Comprehensive Cancer Ctr
Address1450 Third St
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UEA, Norwich (UK)PhD2015Tumor Angiogenesis
    Alma Mater Studiorum, Bologna (IT)Habilitation2008Biology
    Alma Mater Studiorum, Bologna (IT)Master2007Medical Biotechnology
    Alma Mater Studiorum, Bologna (IT)Bachelor2004Biotechnology
    Collapse Awards and Honors
    EACR2013Travel Fellowship Award
    BSCB2012Honor Fell / Company of Biologists Travel Awards
    Sapienza University (Rome)2007Unipharma-Graduates Project 3

    Collapse Overview 
    Collapse Overview
    My research interest lies in revealing the dialogue between tumor cell compartment and the vascular niche in tumor progression and therapeutic resistance.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ruiz-Saenz A, Dreyer C, Campbell MR, Steri V, Gulizia NP, Moasser MM. HER2 amplification in tumors activates PI3K/Akt signaling independent of HER3. Cancer Res. 2018 May 14. PMID: 29760043.
      View in: PubMed
    2. He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoral high endothelial venules. J Pathol. 2018 Mar 30. PMID: 29603739.
      View in: PubMed
    3. Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017 04 12; 9(385). PMID: 28404866.
      View in: PubMed
    4. Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, Fontana F, Hurchla MA, Knolhoff BL, Meyer MA, Morgan EA, Tomasson JC, Novack JS, Zou W, Faccio R, Novack DV, Robinson SD, Teitelbaum SL, DeNardo DG, Schneider JG, Weilbaecher KN. Antagonizing Integrin ß3 Increases Immunosuppression in Cancer. Cancer Res. 2016 06 15; 76(12):3484-95. PMID: 27216180; PMCID: PMC4944657 [Available on 06/15/17].
    5. Ellison TS, Atkinson SJ, Steri V, Kirkup BM, Preedy ME, Johnson RT, Ruhrberg C, Edwards DR, Schneider JG, Weilbaecher K, Robinson SD. Suppression of ß3-integrin in mice triggers a neuropilin-1-dependent change in focal adhesion remodelling that can be targeted to block pathological angiogenesis. Dis Model Mech. 2015 Sep; 8(9):1105-19. PMID: 26159543; PMCID: PMC4582102.
    6. Atkinson SJ, Ellison TS, Steri V, Gould E, Robinson SD. Redefining the role(s) of endothelial avß3-integrin in angiogenesis. Biochem Soc Trans. 2014 Dec; 42(6):1590-5. PMID: 25399575.
      View in: PubMed
    7. Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, Edwards D, Fruttiger M, Hodivala-Dilke KM, Robinson SD. Acute depletion of endothelial ß3-integrin transiently inhibits tumor growth and angiogenesis in mice. Circ Res. 2014 Jan 03; 114(1):79-91. PMID: 24103390.
      View in: PubMed
    8. Steri V, Farnedi A, Montinari E, Foschini MP. Fast track biopsy method: a rapid approach to preoperative diagnoses. Pathologica. 2010 Apr; 102(2):41-5. PMID: 23596755.
      View in: PubMed
    9. Faure-André G, Vargas P, Yuseff MI, Heuzé M, Diaz J, Lankar D, Steri V, Manry J, Hugues S, Vascotto F, Boulanger J, Raposo G, Bono MR, Rosemblatt M, Piel M, Lennon-Duménil AM. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science. 2008 Dec 12; 322(5908):1705-10. PMID: 19074353.
      View in: PubMed
    10. Piccioli D, Tavarini S, Borgogni E, Steri V, Nuti S, Sammicheli C, Bardelli M, Montagna D, Locatelli F, Wack A. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood. 2007 Jun 15; 109(12):5371-9. PMID: 17332250.
      View in: PubMed
    11. Steri V., Oronsky B., Scicinski J, Bergers B.AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1245. Abstract 1245: RRx-001 is effective in temozolomide-sensitive and resistant GBM.